Criteria for selecting patients to perform staged parathyroidectomy
https://doi.org/10.37489/2949-1924-0009
Abstract
Low-invasive ultrasound-controlled interventions are promising methods for treating primary hyperparathyroidism (PHPT) with proven clinical effects. In the presence of objective advantages of low-invasive ultrasound-controlled staged parathyroidectomy, indications for its implementation are not fully formed, and there is no consensus on the criteria for selecting patients. The study formed the criteria for selecting patients with primary hyperparathyroidism to perform staged parathyroidectomy. In 2012–2020, staged parathyroidectomy was performed in 61 patients. Staged parathyroidectomy was performed according to the original technique (patent RU No. 2392898 "Method of treatment of primary and secondary hyperparathyroidism"). Indications for the surgical treatment of PHPT were determined using Russian clinical guidelines. According to the results obtained during the long-term postoperative period, the effectiveness of staged parathyroidectomy was 90.2%. This indicator was achieved because of other things and strict selection of patients. Based on the analysis of the results obtained, the criteria for selecting patients and contraindications for performing staged parathyroidectomy were formed.
About the Authors
S. N. PamputisRussian Federation
Doctor of Medical Sciences, Prof. Department of surgical diseases. RSCI Author ID: 828589.
Yaroslavl
Competing Interests:
The authors declare no conflict of interest
Yu. K. Aleksandrov
Russian Federation
Doctor of Medical Sciences, Prof., head. Department of surgical diseases. RSCI Author ID: 507940.
Yaroslavl
Competing Interests:
The authors declare no conflict of interest
Y. N. Patrunov
Russian Federation
Patrunov Yu. N. — Candidate of Medical Sciences, head of Department of ultrasound diagnostic. RSCI Author ID: 938096.
Yaroslavl
Competing Interests:
The authors declare no conflict of interest
I. E. Belyakov
Russian Federation
Belyakov I. E. — Candidate of Medical Sciences, assistant prof. Department of surgical diseases. RSCI Author ID: 507940.
Yaroslavl
Competing Interests:
The authors declare no conflict of interest
E. N. Lopatnicova
Russian Federation
Lopatnicova Е. N. — Candidate of Medical Sciences, assistant prof. Department of Therapy, Faculty of Pediatrics. RSCI Author ID: 713889.
Yaroslavl
Competing Interests:
The authors declare no conflict of interest
References
1. Pamputis S, Patrunov Y, Sencha A et al. Efficacy of ultrasound-guided percutaneous laser ablation in patients with primary Hyperparathyroidism // European Congress of Radiology, Vienna, Austria, March 2017. — Р. 0178.
2. Eun Ju Ha, Jung Hwan Baek, Sun Mi Baek. Minimally Invasive Treatment for Benign Parathyroid Lesions: Treatment Efficacy and Safety Based on Nodule Characteristics. Korean Journal of Radiology. August 2020;21(12). doi: 10.3348/kjr.2020.0037
3. Пампутис С. Н., Лопатникова Е. Н. Интерстициальная лазерная фотокоагуляция у больных с первичным и вторичным гиперпаратиреозом // Сборник тезисов II Всероссийского конгресса «Инновационные технологии в эндокринологии», Москва, 25–28 мая 2014. — С. 472.
4. Lifeng Gong, Weigang Tang, Jingkui Lu, Wei Xu. Тhermal ablation versus parathyroidectomy for secondary hyperparathyroidism: A Meta-analysis. International Journal of Surgery (London, England). August 2019;70. doi: 10.1016/j.ijsu.2019.08.004
5. Jiang T, Chen F, Zhou X, Hu Y. Percutaneous Ultrasound — Guided Laser Ablation with Contrast — Enhanced Ultrasonography for Hyperfunctioning Parathyroid Adenoma: A Preliminary Case Series. Int. J. Endocrinol. 2015;673:604. doi: 10.1155/2015/673604
6. Пампутис С. Н. Оценка эффективности чрескожной лазерной аблации при лечении первичного гиперпаратиреоза. Современная наука: Актуальные проблемы теории и практики. Серия Естественные и технические науки. М.: Научные технологии. 2018;(4):151–4.
7. Xiao-Jing Cao, Zhen-Long Zhao, Ying Wei, MingAn Yu. Efficacy and safety of microwave ablation treatment for secondary hyperparathyroidism: systematic review and meta-analysis. International Journal of Hyperthermia. January 2020;37(1):316– 23. doi: 10.1080/02656736.2020.1744741
8. Zhao J, Qian L, Zu Y et al. Efficacy of ablation therapy for secondary hyperparathyroidism by ultrasound guided percutaneous thermoablation. Ultrasound. Med. Biol. 2016;42(5):1058–65.
9. Haoyang Ma, Chun Ouyang, Yaoyu Huang Ningning Wang. Comparison of microwave ablation treatments in patients with renal secondary and primary hyperparathyroidism. Renal Failure. November 2020;42(1):66–76. doi: 10.1080/0886022X.2019.1707097
10. Zhen-Long Zhao, Ying Wei, Li-Li Peng, MingAn Yu. Complications encountered in the treatment of primary and secondary hyperparathyroidism with microwave ablation — a retrospective study. International Journal of Hyperthermia. January 2019;36(1):1264–71. doi: 10.1080/02656736.2019.1699965
11. Ying Wei, Cheng-Zhong Peng, Shu-Rong Wang, Jun-Feng He. Effectiveness and Safety of Thermal Ablation in the Treatment of Primary Hyperparathyroidism: A Multicenter Study. Journal of Clinical Endocrinology & Metabolism. April 2021. doi: 10.1210/clinem/dgab240
12. Zongli Diao, Linxue Qian, Changsheng Teng, Na Zhang. Microwave ablation versus parathyroidectomy for severe secondary hyperparathyroidism in patients on hemodialysis: a retrospective multicenter study. International Journal of Hyperthermia. January 2021;38(1):213–9. doi: 10.1080/02656736.2021.1885754
13. Fangyi Liu, Xiaoling Yu, Zhoulu Liu, Zhi Qiao. Comparison of ultrasound-guided percutaneous microwave ablation and parathyroidectomy for primary hyperparathyroidism. International Journal of Hyperthermia. January 2019;36(1):835– 40. doi: 10.1080/02656736.2019.1645365
14. Lifeng Gong, Weigang Tang, Jingkui Lu, Wei Xu. Тhermal ablation versus parathyroidectomy for secondary hyperparathyroidism: A Meta-analysis. International Journal of Surgery (London, England). August 2019;70. doi: 10.1016/j.ijsu.2019.08.004
15. Ying Wei, Cheng-Zhong Peng, Shu-Rong Wang, Jun-Feng He. Effectiveness and Safety of Thermal Ablation in the Treatment of Primary Hyperparathyroidism: A Multicenter Study. Journal of Clinical Endocrinology & Metabolism. April 2021. doi: 10.1210/clinem/dgab240
16. Liu C, Wu B, Huang P et al. US — Guided percutaneous microwave ablation for primary hyperparathyroidism with parathyroid nodules: feasibility and safety study. J. Vasc. Interv. Radiol. 2016;27(6):867–75.
17. Jung Hwan Baek, Auh Whan Park. Radiofrequency and Laser Ablation of Thyroid Nodules and Parathyroid Adenoma. January 2021. doi: 10.1016/B978-0-323-66127-0.00016–8
18. Haoyang Ma, Chun Ouyang, Yaoyu Huang Ningning Wang. Comparison of microwave ablation treatments in patients with renal secondary and primary hyperparathyroidism. Renal Failure. November 2020;42(1):66–76. doi: 10.1080/0886022X.2019.1707097
19. Xiao-Jing Cao, Zhen-Long Zhao, Ying Wei, Li-Li Peng, Yan Li & Ming-An Yu. Efficacy and safety of microwave ablation treatment for secondary hyperparathyroidism: systematic review and meta-analysis. International Journal of Hyperthermia. 2020;37:1, 316–23. doi: 10.1080/02656736.2020.1744741
20. Пампутис С. Н., Александров Ю. К., Патрунов Ю. Н. Верификация патологических изменений околощитовидных желез по результатам определения уровня паратиреоидного гормона в аспирационном материале. Хирургия. Журнал им. Н. И. Пирогова. 2013;(5):40–4.
21. Silva Rita, Cavadas Daniela, Vicente Carla, Coutinho Jose. Parathyroid cyst: differential diagnosis. BMJ Case Rep. 2020 Oct 10;13(10):e232017. doi: 10.1136/bcr-2019-232017
Review
For citations:
Pamputis S.N., Aleksandrov Yu.K., Patrunov Y.N., Belyakov I.E., Lopatnicova E.N. Criteria for selecting patients to perform staged parathyroidectomy. Patient-Oriented Medicine and Pharmacy. 2023;1(2):15-20. (In Russ.) https://doi.org/10.37489/2949-1924-0009